Preliminary results of fludarabine, idarubicine and ARA-C as conditioning regimen for allogeneic stem cell transplantation.

被引：0
|
作者：
Lerner, D [1 ]
Pigneux, A [1 ]
Agape, P [1 ]
Lounici, A [1 ]
Fabéres, C [1 ]
Marit, G [1 ]
Cony-Makhoul, P [1 ]
Dazey, B [1 ]
Cousin, T [1 ]
Reiffers, J [1 ]
Boiron, JM [1 ]
机构：
[1] CHU Bordeaux, Hop Haut Leveque, Serv Malad Sang, F-33604 Pessac, France
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4517
引用
收藏
页码：352B / 352B
页数：1
相关论文
共 50 条
  • [1] Preliminary results of an non-myeloablative conditioning regimen for allogeneic stem cell transplantation.
    Mackinnon, S
    Kottaridis, P
    Perry, A
    Chakrabarti, S
    Milligan, DW
    Pettengell, R
    Chopra, R
    Morgan, G
    Hale, G
    Waldmann, H
    Linch, DC
    Devereux, S
    Goldstone, AH
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 31 - 31
  • [2] Nonmyeloablative stem cell transplantation using fludarabine-based conditioning regimen (preliminary results).
    Kim, I
    Jung, JY
    Lee, DH
    Song, HH
    Lee, MH
    Yoon, SS
    Kim, CS
    Park, S
    Kim, BK
    Kim, NK
    [J]. BLOOD, 2001, 98 (11) : 376B - 376B
  • [3] Comparison between BEAM and lomustine, Ara-C, etoposide and melphalan as conditioning regimen before stem cell transplantation. A single-centre experience
    Grillo, G.
    Marenco, P.
    Bertani, G.
    Zucchetti, E.
    Turrini, M.
    Brasca, P.
    Gabutti, C.
    Morra, E.
    [J]. BONE MARROW TRANSPLANTATION, 2009, 43 : S194 - S195
  • [4] Fludarabine and Ara-C followed by allogeneic stem cell transplantation for the patients with AML with multilineage dysplasia and RAEB-2.
    Yoshioka, S
    Ishikawa, T
    Ichinohe, T
    Kobayashi, M
    Takao, S
    Takaori, A
    Imada, K
    Kadowaki, N
    Hori, T
    Takayama, H
    Okazaki, T
    Uchiyama, T
    [J]. BLOOD, 2003, 102 (11) : 331B - 331B
  • [5] Treosulfan/fludarabine as conditioning regimen for allogeneic stem cell transplantation in multiple myeloma.
    Knauf, WU
    Blau, W
    Ruutu, T
    Einsele, H
    Thiel, E
    Freund, M
    Casper, J
    [J]. BLOOD, 2003, 102 (11) : 711A - 711A
  • [6] Fludarabine and busulfan as conditioning regimen in allogeneic stem cell transplantation: comparison with BuCy2
    Fedele, R.
    Moscato, T.
    Massara, E.
    Messina, G.
    Iacopino, O.
    Pontari, A.
    Spiniello, E.
    Callea, I.
    Garreffa, C.
    Martino, M.
    Console, G.
    Gallo, G.
    Princi, D.
    Monteleone, R.
    Irrera, G.
    Iacopino, P.
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S418 - S419
  • [7] Toxicity-reduced conditioning with treosulfan and fludarabine prior to allogeneic blood stem cell transplantation.
    Casper, J
    Wilhelm, S
    Steiner, B
    Wolff, D
    Hammer, U
    Wegener, R
    Kleine, HD
    Freund, M
    [J]. BLOOD, 2000, 96 (11) : 298B - 298B
  • [8] Lace(lomustine, ARA-C, cyclophosphamide and etoposide): An effective conditioning regimen for autologous and allogeneic transplantation with minimal regimen-related toxicity
    Orchard, K
    Lyttelton, MP
    Abrahamson, G
    Stem, S
    Abboudi, Z
    McGuigan, D
    Giles, C
    Kanfer, EJ
    Samson, D
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 969 - 969
  • [9] Conditioning with treosulfan and fludarabine for allogeneic blood stem cell transplantation
    Casper, J
    Steiner, B
    Wolff, D
    Kleine, HD
    Wilhelm, S
    Hammer, U
    von Wurmb, N
    Roeber, S
    Wegener, R
    Freund, M
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S285 - S286
  • [10] LACE (lomustine, ara-C, cyclophosphamide and etoposide): An effective conditioning regimen for autologous and allogeneic transplantation with minimal toxicity.
    Orchard, K
    Giles, C
    Apperley, J
    Goldman, JM
    Kanfer, EJ
    Samson, D
    [J]. BLOOD, 1997, 90 (10) : 1855 - 1855
12345